https://www.avient.com/investor-center/news/polyone-announces-public-offering-common-shares
You may access these documents for free by visiting the
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Global%2520Engineered%2520Materials.pdf
Nikrant
Page 67
United
States
36%
Europe
36%
Canada
2%
Asia
20%
Latin
America
2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions
At a Glance
Appliance
6% Building &
Construction
3%
Wire & Cable
14%
Electrical &
Electronics
14%Consumer
21%
Packaging
5%
Industrial
8%
Misc.
3%
HealthCare
5%
Transportation
21%
America
6%
2011 Revenue by Industry Segment2011 Revenue by Industry Segment
1.1% 1.3%
3.4%
5.1%
9.6%
8.0%
12-16%
2006 2007 2008 2009 2010 2011 2015
Operating Income % of Sales
Target
Expanding ProfitsExpanding Profits
Page 68
Value Proposition
• GSEM is a global leader providing complete specialty solutions encompassing
innovative technologies and services to enable customer success
Transformation Highlights
• Dramatic turnaround of the Engineered Materials business through mix
improvement and specialty focus
Value Proposition and Transformation Highlights
improvement and specialty focus
• GLS acquisition successfully integrated, having more than
doubled earnings in 3 years
• PolyOne culture and strategy now engrained worldwide
• Expansion into healthcare with dedicated resources
> $15B Addressable Market
Page 69
• Polymer design, formulation and service expertise
• Broad, global technology base and regional centers
of excellence
• Ten innovation centers around the world
Key Differentiators
• Ten innovation centers around the world
• Specialty brand leadership with
PolyOne, GLS, NEU and ECCOH
• Ability to leverage global key
account team
Page 70
From Volume
Commodity-driven product portfolio
To Value
Specialty technology and solutions
EM North America Transformation
Volume Sales Gross Margin $
Mix Transformation – Executing the Strategy
2006 2011 2006 2011 2006 2011
Page 71
$12
$29
Operating Income
($ in millions)
• Provided access to new customers
in specialized, high-growth markets
such as healthcare and consumer
• Strategic partner to many of the
world’s best-known companies
GLS Integration Success
16.9%
8.2%
2007 2011
2007 2011
Working Capital % of Sales
• Complementary global footprint
provided additional cross-selling
opportunities
• Opportunity to expand margins
and drive working capital
improvement while remaining
customer-focused
Page 72
$1.3
$27.6
2006 2011
Healthcare Revenue
• Investment in dedicated
healthcare team to drive
penetration and growth
• Leverage product portfolio
globally & win specialty business
Areas of Focus
$10.5
$117.9
2006 2011
Consumer Revenue
2006 2011globally & win specialty business
in targeted markets
• Aggressively commercialize
specialty innovation platforms
• Utilize our innovation centers to
influence OEM design
(Revenue in $ millions)
Page 73
• Carbon Nanotube Formulations
� Applications: Semiconductor equipment, hard drives
� Customer benefits: Scrap cost reduction and
clean conductivity
• Thermally Conductive Solutions
Applications: Sockets and bulb holders for LED lighting
Key Innovations
� Applications: Sockets and bulb holders for LED lighting
� Customer benefits: Cost reduction, energy saving, and
design flexibility
• FDA-Regulated TPEs
� Applications: Food packaging seals, intravenous delivery
systems, medical stoppers, prefilled syringes
� Customer benefits: Clean and safe elastomers for highly
regulated applications
Page 74
Critical Imperatives and 2015 Goal
Critical Imperatives
• Commercialize critical new technology platforms
• Manage the mix as we continue to drive
the transformation
• Global translation of commercial successes
2015 Goal
• 12 - 16% return on sales
Page 75
Page 76
https://www.avient.com/sites/default/files/2022-11/PREPERM RF Materials 1-pager.pdf
Part weight reduction
• Low loss tangent
• RoHS & REACH compliant solution
• Halogen- and heavy metal-free solution
• Recyclable
Copyright © 2022, Avient Corporation.
https://www.avient.com/sites/default/files/2020-11/eccoh-product-selection-guide-en.pdf
Continuous Use Temp °C 90°C 90°C 105°C 90°C 125°C 90°C 90°C 105°C
SMOKE DENSITY (MAX)
Flaming Mode 45 104 312 163 312 118 98 60 101 121
Non-Flaming Mode 212 279 303 416 297 369 296 223 296 393
FEATURES
ESCR x
Flame Performance x x x x x
Heat Resistance x x x
High Char Forming x
Low Temperature
Performance x x
Mechanical Properties x x x
Oil Resistance x
UL Listed Halogen-Free x x x
FEATURES
Wire and Cable
• Highly flame retardant
• Very low toxicity and smoke density
• Many grades are cross-linkable
• Can be processed with color or additive
concentrate, and with UV stabilizer
Pipe and Fittings
• Highly flame retardant
• Very low toxicity and smoke density
• Suitable for extrusion, injection molding
ECCOH™
ECCOH™ non-halogenated formulations
re designed to be highly flame retardant
with extremely low toxicity and smoke
density.
https://www.avient.com/sites/default/files/2023-06/EZR Gun Grip Case Study.pdf
CORE plastisols offer strength and
flexibility while being phthalate-free, providing an
alternative for markets and applications affected by
strict guidelines.
https://www.avient.com/sites/default/files/2021-10/remafin-ep-white-masterbatches-for-pharma-application-bulletin_0.pdf
KEY CHARACTERISTICS
• Manufactured under change control principles
beyond CAS number (similar level as MEVOPUR
concentrates), reducing risk of change
• Free from animal-derived substances and
phthalates
• Suitable for blown film, injection molding,
blow molding and extrusion
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1
- USP chapters , including Class VI,
a requirement for ophthalmic and nasal drugs
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
- USP and USP light transmission
• Registered Drug Master File (Type III)
• Food contact compliance established with
FDA/EU*
APPLICATION BULLETIN
CARRIER
MATERIAL
PIGMENT
CONTENT/TYPE
LIGHT
FASTNESS
THERMAL
STABILITY
PRODUCT
CODE
HDPE 50% TiO2
8 300°C PH00075525
LLDPE 60% TiO2
8 300°C PL00075542
LLDPE 70% TiO2
8 300°C PL00075545
PP 50% TiO2
8 300°C PP00075717
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Morgan%2520Stanley%2520Conference.pdf
USE OF
NON-GAAP
MEASURES
PolyOne Corporation 3
• This presentation includes the use of both GAAP (generally accepted
accounting principles) and non-GAAP financial measures.
Adjusted EPS attributable to PolyOne common shareholders is calculated as follows:
2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016 2017
Net income from continuing operations attributable
to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5
Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — —
Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9
Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8)
Adjusted net income from continuing operations
attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6
Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1
Adjusted EPS attributable to PolyOne common
shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation
1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from
personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation
costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or
disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; the effect of changes in accounting principles or other
such laws or provisions affecting reported results and tax adjustments.
https://www.avient.com/sites/default/files/resources/September%2520Investor%2520Presentation.pdf
USE OF
NON-GAAP
MEASURES
PolyOne Corporation 3
• This presentation includes the use of both GAAP (generally accepted
accounting principles) and non-GAAP financial measures.
Adjusted EPS attributable to PolyOne common shareholders is calculated as follows:
2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016 2017 2018
Net income from continuing operations attributable to
PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1
Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — — —
Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5
Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3)
Adjusted net income from continuing operations
attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3
Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4
Adjusted EPS attributable to PolyOne common
shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation
1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to
contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension
and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and
equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-
recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
https://www.avient.com/sites/default/files/2020-11/oncap-denesting-case-study.pdf
The company was running out of time and
facing the reality of being unable to deliver an effective
solution and, ultimately, losing the account.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Recast%2520Financial%2520Information%2520-%2520ASU%25202017-07%2520-%2520Pension%2520and%2520Postretirement%2520Costs.pdf
The new accounting standard is effective January 1, 2018 and
requires all components of annual periodic pension and postretirement
costs, other than service costs, to be presented below Operating Income.